DocDollars

Catalyst Pharmaceuticals, Inc.

FL · United States · Reporting entity ID 100000481813

Total reported 2019–2025
$5.50M
#675 of 2,960 reporting companies — 0% of all reported industry payments
$2.84M in general payments across 21,416 records, plus $2.65M in research funding across 189 records.

How it breaks down

General payments $2,844,866
Research funding $2,654,638

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Catalyst Pharmaceuticals, Inc. reported $5.50M to US doctors and teaching hospitals from 2019 to 2025, ranking #675 of 2,960 reporting companies. 48% of that was research funding and 52% general payments such as consulting, speaking, food and travel. 21,416 general payment records and 189 research records were filed.

Common questions about Catalyst Pharmaceuticals, Inc.

How much has Catalyst Pharmaceuticals, Inc. paid US doctors?

Catalyst Pharmaceuticals, Inc. reported $5,499,504 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,844,866 in general payments, $2,654,638 in research funding.

How does Catalyst Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #675 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Catalyst Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.